About Psyomics
Psyomics is a company based in Cambridge (United Kingdom) founded in 2015 by Sabine Bahn. Psyomics has raised $10.29 million across 7 funding rounds from investors including Newable, Cambridge Enterprise and European Union. The company has 14 employees as of December 31, 2023. Psyomics offers products and services including Censeo. Psyomics operates in a competitive market with competitors including Cognoa, DAS Health, Blueprint, Spectrum AI and Opeeka, among others.
- Headquarter Cambridge, United Kingdom
- Employees 14 as on 31 Dec, 2023
- Founders Sabine Bahn
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Psyomics Ltd
- Date of Incorporation 04 Mar, 2015
- Jurisdiction CAMBRIDGE, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.29 M (USD)
in 7 rounds
-
Latest Funding Round
$3.3 M (USD), Series B
Jan 17, 2022
-
Investors
Newable
& 7 more
-
Employee Count
14
as on Dec 31, 2023
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Psyomics
Psyomics offers a comprehensive portfolio of products and services, including Censeo.
Digital tool for mental health triage and assessments to aid decision-making.
People of Psyomics
Unlock access to complete
Unlock access to complete
Funding Insights of Psyomics
Psyomics has successfully raised a total of $10.29M across 7 strategic funding rounds. The most recent funding activity was a Series B round of $3.3 million completed in January 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Psyomics
Psyomics has secured backing from 8 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include Newable, Cambridge Enterprise and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Tech companies are invested in by Parkwalk venture capital firm.
|
Locked | Locked | Locked | |
|
Venture capital funds focused on life sciences and tech startups
|
Locked | Locked | Locked | |
|
Government agency and accelerator focusing on innovative startups and SMEs
|
Locked | Locked | Locked |
Investor details for Psyomics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Psyomics
Investment portfolio details for Psyomics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Psyomics
Detailed financials for Psyomics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Psyomics Comparisons
Peer comparison for Psyomics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Psyomics
Psyomics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cognoa, DAS Health, Blueprint, Spectrum AI and Opeeka, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI-powered diagnostic tools for early childhood developmental disorders are developed.
|
|
| Locked | Locked | Locked |
Behavioral health assessments and IT management solutions are offered.
|
|
| Locked | Locked | Locked |
E-commerce purchases are enabled via social media messaging platforms.
|
|
| Locked | Locked | Locked |
AI-enabled behavior analysis tool for autism
|
|
| Locked | Locked | Locked |
AI-based mental health assessment software is offered to doctors.
|
Detailed competitors of Psyomics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Psyomics
Complete news archive for Psyomics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Psyomics
Psyomics was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Psyomics is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Melinda R is the current CEO of Psyomics.
Psyomics is a funded company, having raised a total of $10.29M across 7 funding rounds to date.
As of Dec 31, 2023, the latest employee count at Psyomics is 14.
Psyomics was founded in 2015 in Cambridge, United Kingdom, within the mental health technology sector. A digital platform is developed for diagnostics, integrating biological data with information gathered via web-based questionnaires. Operations focus on workplaces and clinical trials, where personalized insights, educational resources, and advice on mental health concerns are delivered to employees. Leadership includes a co-founder, COO, and CEO guiding these efforts.
Psyomics's top competitors include Spectrum AI, Cognoa and DAS Health.
Psyomics offers Censeo.
Psyomics has 8 investors. Key investors include Newable, Cambridge Enterprise, European Union, Martlet Capital, and Parkwalk.
The valuation of Psyomics is $10.85M as of Jan 2022.